标题
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer
作者
关键词
-
出版物
Nature Reviews Clinical Oncology
Volume 19, Issue 2, Pages 114-131
出版商
Springer Science and Business Media LLC
发表日期
2021-11-24
DOI
10.1038/s41571-021-00579-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Radiotherapy delivered before CDK4/6 inhibitors mediates superior therapeutic effects in ER+ breast cancer
- (2021) Giulia Petroni et al. CLINICAL CANCER RESEARCH
- PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy
- (2021) Fu-Cheng Chuang et al. PLoS One
- Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy
- (2021) Guang-Yi Sun et al. Frontiers in Oncology
- Control of replication stress and mitosis in colorectal cancer stem cells through the interplay of PARP1, MRE11 and RAD51
- (2021) Gwenola Manic et al. CELL DEATH AND DIFFERENTIATION
- An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer
- (2021) Ning Li et al. CLINICAL CANCER RESEARCH
- Radiotherapy-exposed CD8+ and CD4+ neoantigens enhance tumor control
- (2021) Claire Lhuillier et al. JOURNAL OF CLINICAL INVESTIGATION
- Intratumoral heterogeneity in cancer progression and response to immunotherapy
- (2021) Ilio Vitale et al. NATURE MEDICINE
- PD-L1 as a biomarker of response to immune-checkpoint inhibitors
- (2021) Deborah Blythe Doroshow et al. Nature Reviews Clinical Oncology
- Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
- (2021) Daniel P. Kulinich et al. ACTA NEUROCHIRURGICA
- PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
- (2021) Roman M. Chabanon et al. CANCER RESEARCH
- PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancer
- (2021) N. Zhang et al. Clinical & Translational Oncology
- Phase I study of ceralasertib (AZD6738), a novel DNA damage repair agent, in combination with weekly paclitaxel in refractory cancer
- (2021) Seung Tae Kim et al. CLINICAL CANCER RESEARCH
- Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
- (2021) Nasser K Altorki et al. LANCET ONCOLOGY
- A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma
- (2021) Eddy S. Yang et al. RADIOTHERAPY AND ONCOLOGY
- Systemic toxicity of chloroquine and hydroxychloroquine: prevalence, mechanisms, risk factors, prognostic and screening possibilities
- (2021) Romain Muller RHEUMATOLOGY INTERNATIONAL
- The Targeting of MRE11 or RAD51 Sensitizes Colorectal Cancer Stem Cells to CHK1 Inhibition
- (2021) Luca Mattiello et al. Cancers
- Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
- (2021) Lina Lüttich et al. Cancers
- Rapamycin Promotes ROS-Mediated Cell Death via Functional Inhibition of xCT Expression in Melanoma Under γ-Irradiation
- (2021) Yunseo Woo et al. Frontiers in Oncology
- Radiotherapy and immunotherapy combinations in the treatment of patients with metastatic disease: current status and future focus
- (2021) William Tyler Turchan et al. CLINICAL CANCER RESEARCH
- Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers
- (2020) Ling F. Ye et al. ACS Chemical Biology
- The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression
- (2020) Guang Lei et al. CELL RESEARCH
- The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo
- (2020) Salome Paillas et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase 1b/2a study of galunisertib, a small molecule inhibitor of transforming growth factor-beta receptor I, in combination with standard temozolomide-based radiochemotherapy in patients with newly diagnosed malignant glioma
- (2020) Antje Wick et al. INVESTIGATIONAL NEW DRUGS
- PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells
- (2020) Chuan Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Insulin–PI3K signalling: an evolutionarily insulated metabolic driver of cancer
- (2020) Benjamin D. Hopkins et al. Nature Reviews Endocrinology
- mTOR at the nexus of nutrition, growth, ageing and disease
- (2020) Grace Y. Liu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability
- (2020) Katerina D. Fagan-Solis et al. Cell Reports
- Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances
- (2020) Hanne Lind et al. Journal for ImmunoTherapy of Cancer
- Cyclin-dependent kinase 4/6 inhibitors combined with radiation therapy for patients with metastatic breast cancer
- (2020) Ivica Ratosa et al. Clinical Breast Cancer
- Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy
- (2020) Linlin Yang et al. CLINICAL CANCER RESEARCH
- Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation
- (2020) Changhoon Choi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Small molecules, big impact: 20 years of targeted therapy in oncology
- (2020) Philippe L Bedard et al. LANCET
- CHK1/2 Inhibitor Prexasertib Suppresses NOTCH Signaling and Enhances Cytotoxicity of Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma
- (2020) Ling Zeng et al. MOLECULAR CANCER THERAPEUTICS
- FGFR inhibition enhances sensitivity to radiation in non-small cell lung cancer.
- (2020) Gopika SenthilKumar et al. MOLECULAR CANCER THERAPEUTICS
- Pharmacologic Inhibitor of DNA-PK, M3814, Potentiates Radiotherapy and Regresses Human Tumors in Mouse Models
- (2020) Frank T. Zenke et al. MOLECULAR CANCER THERAPEUTICS
- Combination of CHEK1/2 inhibition and ionizing radiation results in abscopal tumor response through increased micronuclei formation
- (2020) Hann-Hsiang Chao et al. ONCOGENE
- ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma
- (2020) Hailong Sheng et al. Journal for ImmunoTherapy of Cancer
- Clinical development of therapies targeting TGFβ: current knowledge and future perspectives.
- (2020) D. Ciardiello et al. ANNALS OF ONCOLOGY
- Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial
- (2020) L. Paz-Ares et al. ANNALS OF ONCOLOGY
- Concurrent use of palbociclib and radiation therapy: single-centre experience and review of the literature
- (2020) Arnaud Beddok et al. BRITISH JOURNAL OF CANCER
- Radiation-induced adaptive response: new potential for cancer treatment
- (2020) C. Norman Coleman et al. CLINICAL CANCER RESEARCH
- Phase I Trial of First-in-Class ATR Inhibitor M6620 (VX-970) as Monotherapy or in Combination With Carboplatin in Patients With Advanced Solid Tumors
- (2020) Timothy A. Yap et al. JOURNAL OF CLINICAL ONCOLOGY
- Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study
- (2020) Xu-Shan Sun et al. LANCET ONCOLOGY
- Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy
- (2020) Takahiro Yamazaki et al. NATURE IMMUNOLOGY
- MET-dependent solid tumours — molecular diagnosis and targeted therapy
- (2020) Robin Guo et al. Nature Reviews Clinical Oncology
- TGFβ biology in cancer progression and immunotherapy
- (2020) Rik Derynck et al. Nature Reviews Clinical Oncology
- Human organoids: model systems for human biology and medicine
- (2020) Jihoon Kim et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients
- (2020) Andrea Emanuele Guerini et al. Scientific Reports
- Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
- (2020) Patrick Yung Wen et al. ESMO Open
- Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
- (2020) Inge Compter et al. Autophagy
- Phase I trial of Debio 1143, an antagonist of inhibitor of apoptosis proteins, combined with cisplatin-chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head & neck
- (2020) Christophe Le Tourneau et al. CLINICAL CANCER RESEARCH
- Positron Emission Tomography Imaging of Functional TGFβ Activity and Benefit of TGFβ Inhibition in Irradiated Intracranial Tumors
- (2020) Alba Gonzalez-Junca et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial
- (2020) Pierre Loap et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A phase I/II study of ribociclib following radiation therapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)
- (2020) Mariko DeWire et al. JOURNAL OF NEURO-ONCOLOGY
- The molecular basis and disease relevance of non-homologous DNA end joining
- (2020) Bailin Zhao et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pyrotinib enhances the radiosensitivity of HER2‑overexpressing gastric and breast cancer cells
- (2020) Tingting Huang et al. ONCOLOGY REPORTS
- Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
- (2020) D. Day et al. ORAL ONCOLOGY
- Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells
- (2020) Demet Candas-Green et al. Nature Communications
- The influence of PI3K inhibition on the radiotherapy response of head and neck cancer cells
- (2020) Mary Glorieux et al. Scientific Reports
- Activin A promotes regulatory T cell-mediated immunosuppression in irradiated breast cancer
- (2020) Mara De Martino et al. Cancer Immunology Research
- A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours
- (2020) Mark T. J. van Bussel et al. BRITISH JOURNAL OF CANCER
- Immunomodulation by targeted anticancer agents
- (2020) Giulia Petroni et al. CANCER CELL
- Phase I and Pharmacologic Study of Olaparib in Combination with High-dose Radiotherapy with and without Concurrent Cisplatin for Non–Small Cell Lung Cancer
- (2020) Rosemarie de Haan et al. CLINICAL CANCER RESEARCH
- Phase II Study of Nimotuzumab in Combination with Concurrent Chemoradiotherapy in Patients with Locally Advanced Non-Small-Cell Lung Cancer
- (2020) Nobuyuki Yamamoto et al. Clinical Lung Cancer
- PARP inhibitors coming of age
- (2020) Shani Paluch-Shimon et al. Nature Reviews Clinical Oncology
- The complex balance of PI3K inhibition
- (2020) H. Vanacker et al. ANNALS OF ONCOLOGY
- TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies
- (2019) María E. Rodríguez-Ruiz et al. MOLECULAR CANCER THERAPEUTICS
- Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
- (2019) Panagiotis A Konstantinopoulos et al. LANCET ONCOLOGY
- Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study
- (2019) G. Fleischhack et al. JOURNAL OF NEURO-ONCOLOGY
- ATR Inhibition Potentiates the Radiation-induced Inflammatory Tumor Microenvironment
- (2019) Magnus T. Dillon et al. CLINICAL CANCER RESEARCH
- Inhibition of Nuclear PTEN Tyrosine Phosphorylation Enhances Glioma Radiation Sensitivity through Attenuated DNA Repair
- (2019) Jianhui Ma et al. CANCER CELL
- Differential effects of the Akt inhibitor MK-2206 on migration and radiation sensitivity of glioblastoma cells
- (2019) Cholpon S. Djuzenova et al. BMC CANCER
- Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy
- (2019) Qiang Zhang et al. CANCER RESEARCH
- Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma
- (2019) Daniel R. McGowan et al. EUROPEAN JOURNAL OF CANCER
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck
- (2019) Qiancheng Jing et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer
- (2019) Fabrice André et al. NEW ENGLAND JOURNAL OF MEDICINE
- P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy
- (2019) D.M. Fernández-Aroca et al. CANCER LETTERS
- Autophagy-Independent Functions of the Autophagy Machinery
- (2019) Lorenzo Galluzzi et al. CELL
- Inhibition of CD4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell Carcinomas
- (2019) Eva-Leonne Göttgens et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity
- (2019) Shiying Wu et al. NATURE CELL BIOLOGY
- Autophagy: A Player in response to Oxidative Stress and DNA Damage
- (2019) Serena Galati et al. Oxidative Medicine and Cellular Longevity
- Poly(ADP-ribose) polymerase-1 antagonizes DNA resection at double-strand breaks
- (2019) Marie-Christine Caron et al. Nature Communications
- Enhancing direct cytotoxicity and response to immune checkpoint blockade following ionizing radiation with Wee1 kinase inhibition
- (2019) Priya Patel et al. OncoImmunology
- Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer
- (2019) Willemijn S. M. E. Theelen et al. JAMA Oncology
- Baseline T cell dysfunction by single cell network profiling in metastatic breast cancer patients
- (2019) Silvia C. Formenti et al. Journal for ImmunoTherapy of Cancer
- Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: Preliminary assessment of toxicity
- (2019) Edy Ippolito et al. BREAST
- The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP Inhibition
- (2019) Kalindi Parmar et al. CLINICAL CANCER RESEARCH
- FGFR Signaling as a Candidate Therapeutic Target for Cancers Resistant to Carbon Ion Radiotherapy
- (2019) Narisa Dewi Maulany Darwis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PARP1 Inhibition Radiosensitizes Models of Inflammatory Breast Cancer to Ionizing Radiation
- (2019) Anna R Michmerhuizen et al. MOLECULAR CANCER THERAPEUTICS
- HER2-targeted therapies — a role beyond breast cancer
- (2019) Do-Youn Oh et al. Nature Reviews Clinical Oncology
- Apoptotic caspases inhibit abscopal responses to radiation and identify a new prognostic biomarker for breast cancer patients
- (2019) Maria Esperanza Rodriguez-Ruiz et al. OncoImmunology
- Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients
- (2019) Mutlay Sayan et al. Frontiers in Oncology
- A Phase Ib Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity-Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma
- (2019) Lara A. Dunn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Fluzoparib increases radiation sensitivity of non-small cell lung cancer (NSCLC) cells without BRCA1/2 mutation, a novel PARP1 inhibitor undergoing clinical trials
- (2019) Jing Luo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Selective DNA-PKcs inhibition extends the therapeutic index of localized radiotherapy and chemotherapy
- (2019) Catherine E. Willoughby et al. JOURNAL OF CLINICAL INVESTIGATION
- Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer
- (2019) Kyle C. Cuneo et al. JOURNAL OF CLINICAL ONCOLOGY
- Apatinib potentiates irradiation effect via suppressing PI3K/AKT signaling pathway in hepatocellular carcinoma
- (2019) Junbin Liao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment
- (2019) Ina Patties et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The novel ATR inhibitor BAY 1895344 is efficacious as monotherapy and combined with DNA damage-inducing or repair-compromising therapies in preclinical cancer models
- (2019) Antje M. Wengner et al. MOLECULAR CANCER THERAPEUTICS
- Radiation responses of 2D and 3D glioblastoma cells: a novel, 3D-specific radioprotective role of VEGF/Akt signaling through functional activation of NHEJ
- (2019) Natividad Gomez-Roman et al. MOLECULAR CANCER THERAPEUTICS
- Targeting the MET receptor tyrosine kinase as a strategy for radiosensitization in loco-regionally advanced head and neck squamous cell carcinoma
- (2019) Lluís Nisa et al. MOLECULAR CANCER THERAPEUTICS
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- Synthetic lethality as an engine for cancer drug target discovery
- (2019) Alan Huang et al. NATURE REVIEWS DRUG DISCOVERY
- Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors
- (2019) Neil Vasan et al. SCIENCE
- Anti-Tumor Effect of Inhibition of DNA Damage Response Proteins, ATM and ATR, in Endometrial Cancer Cells
- (2019) Makoto Takeuchi et al. Cancers
- Novel Radiotherapy Technologies in the Treatment of Gastrointestinal Malignancies
- (2019) Shraddha Mahesh Dalwadi et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- A potential new role of ATM inhibitor in radiotherapy: suppressing ionizing Radiation-Activated EGFR
- (2019) Siyuan Tang et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31
- (2019) Saranya Chumsri et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
- (2019) Maria Esperanza Rodriguez-Ruiz et al. NATURE IMMUNOLOGY
- CDK4/6 Inhibitor Palbociclib Amplifies the Radiosensitivity to Nasopharyngeal Carcinoma Cells via Mediating Apoptosis and Suppressing DNA Damage Repair
- (2019) Xianhe Xie et al. OncoTargets and Therapy
- Airway Microbiota Is Associated with Up-Regulation of the PI3K Pathway in Lung Cancer
- (2018) Jun-Chieh J Tsay et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer
- (2018) Jordi Rodon et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer
- (2018) Silvia C. Formenti et al. CLINICAL CANCER RESEARCH
- Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non–Small Cell Lung CancerIn VitroandIn Vivo
- (2018) Sarwat Naz et al. CLINICAL CANCER RESEARCH
- Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer.
- (2018) Sana D. Karam et al. CLINICAL CANCER RESEARCH
- Radiosensitization by the PARP inhibitor olaparib in BRCA1-proficient and deficient high-grade serous ovarian carcinomas
- (2018) Yue Bi et al. GYNECOLOGIC ONCOLOGY
- Cardiotoxicity Assessment After Different Adjuvant Hypofractionated Radiotherapy Concurrently Associated with Trastuzumab in Early Breast Cancer
- (2018) ELISABETTA BONZANO et al. IN VIVO
- Phosphatidylinositol-3-Kinase Mutations Are Associated With Increased Local Failure in Brain Metastases Treated With Radiation
- (2018) Natalie A. Lockney et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors
- (2018) Anish Thomas et al. JOURNAL OF CLINICAL ONCOLOGY
- The DNA-PK Inhibitor VX-984 Enhances the Radiosensitivity of Glioblastoma Cells GrownIn Vitroand as Orthotopic Xenografts
- (2018) Cindy R. Timme et al. MOLECULAR CANCER THERAPEUTICS
- Orally bioavailable and blood-brain-barrier penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice.
- (2018) Jeremy Karlin et al. MOLECULAR CANCER THERAPEUTICS
- Inhibition of Parp1 by BMN673 effectively sensitizes cells to radiotherapy by upsetting the balance of repair pathways processing DNA double-strand breaks
- (2018) Aashish Soni et al. MOLECULAR CANCER THERAPEUTICS
- Chromosomal instability drives metastasis through a cytosolic DNA response
- (2018) Samuel F. Bakhoum et al. NATURE
- The autophagic network and cancer
- (2018) Marissa D. Rybstein et al. NATURE CELL BIOLOGY
- Targeting the PI3K pathway in cancer: are we making headway?
- (2018) Filip Janku et al. Nature Reviews Clinical Oncology
- Synthetic lethal therapies for cancer: what’s next after PARP inhibitors?
- (2018) Alan Ashworth et al. Nature Reviews Clinical Oncology
- Determinants and clinical implications of chromosomal instability in cancer
- (2018) Laurent Sansregret et al. Nature Reviews Clinical Oncology
- Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
- (2018) Yan Lan et al. Science Translational Medicine
- Dual Transforming Growth Factor-β and Programmed Death-1 Blockade: A Strategy for Immune-Excluded Tumors?
- (2018) Claire Vanpouille-Box et al. TRENDS IN IMMUNOLOGY
- Palliative radiotherapy
- (2018) Katie Spencer et al. BMJ-British Medical Journal
- Palliative radiotherapy
- (2018) Katie Spencer et al. BMJ-British Medical Journal
- The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models
- (2018) Stephen T. Durant et al. Science Advances
- Ribociclib plus letrozole and concomitant palliative radiotherapy for metastatic breast cancer
- (2018) Icro Meattini et al. BREAST
- Effects of trastuzumab on locoregional recurrence in human epidermal growth factor receptor 2-overexpressing breast cancer patients treated with chemotherapy and radiotherapy
- (2018) Seung Hyuck Jeon et al. BREAST CANCER RESEARCH AND TREATMENT
- Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia–mutated kinase–mediated DNA damage response
- (2018) Chao-Yuan Huang et al. EUROPEAN JOURNAL OF CANCER
- ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation
- (2018) Frank P. Vendetti et al. JOURNAL OF CLINICAL INVESTIGATION
- ATR inhibition is a promising radiosensitizing strategy for triple negative breast cancer
- (2018) Xinyi Tu et al. MOLECULAR CANCER THERAPEUTICS
- Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
- (2018) Benjamin D. Hopkins et al. NATURE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Optimizing radiation dose and fractionation for the definitive treatment of locally advanced non-small cell lung cancer
- (2018) Michael C. Roach et al. Journal of Thoracic Disease
- Autophagy induced by ionizing radiation promotes cell death over survival in human colorectal cancer cells
- (2018) Fabian Classen et al. EXPERIMENTAL CELL RESEARCH
- Radiotherapy induces responses of lung cancer to CTLA-4 blockade
- (2018) Silvia C. Formenti et al. NATURE MEDICINE
- State-of-the-art strategies for targeting the DNA damage response in cancer
- (2018) Patrick G. Pilié et al. Nature Reviews Clinical Oncology
- Linking cellular stress responses to systemic homeostasis
- (2018) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- PARP inhibition enhances tumor cell–intrinsic immunity in ERCC1-deficient non–small cell lung cancer
- (2018) Roman M. Chabanon et al. JOURNAL OF CLINICAL INVESTIGATION
- Preoperative radiotherapy in breast cancer patients: 32 years of follow-up
- (2017) F.G. Riet et al. EUROPEAN JOURNAL OF CANCER
- Immune recognition of irradiated cancer cells
- (2017) Erik Wennerberg et al. IMMUNOLOGICAL REVIEWS
- Autophagy enhanced the radioresistance of non-small cell lung cancer by regulating ROS level under hypoxia condition
- (2017) Xiaoyan Chen et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy
- (2017) Vivek Narayan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study
- (2017) Shulian Wang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Inhibiting autophagy with chloroquine enhances the anti-tumor effect of high-LET carbon ions via ER stress-related apoptosis
- (2017) Xiaogang Zheng et al. MEDICAL ONCOLOGY
- PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors
- (2017) Leslie A. Parsels et al. MOLECULAR CANCER RESEARCH
- Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an Example
- (2017) Iris Eke et al. MOLECULAR CANCER THERAPEUTICS
- Radiosensitization In Vivo by Histone Deacetylase Inhibition with No Increase in Early Normal Tissue Radiation Toxicity
- (2017) Blaz Groselj et al. MOLECULAR CANCER THERAPEUTICS
- ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway
- (2017) Hui He et al. Molecular Medicine Reports
- Monitoring immune-checkpoint blockade: response evaluation and biomarker development
- (2017) Mizuki Nishino et al. Nature Reviews Clinical Oncology
- Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
- (2017) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- The evolution of brachytherapy for prostate cancer
- (2017) Nicholas G. Zaorsky et al. Nature Reviews Urology
- A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913
- (2017) Prakash Chinnaiyan et al. NEURO-ONCOLOGY
- The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines
- (2017) Fei Shi et al. NEUROSCIENCE
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- PTEN deficiency sensitizes endometrioid endometrial cancer to compound PARP-PI3K inhibition but not PARP inhibition as monotherapy
- (2017) X Bian et al. ONCOGENE
- Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor‐Naïve Advanced Pancreatic Neuroendocrine Tumors
- (2017) Ramon Salazar et al. ONCOLOGIST
- Autophagy Promotes the Repair of Radiation-Induced DNA Damage in Bone Marrow Hematopoietic Cells via Enhanced STAT3 Signaling
- (2017) Fei Xu et al. RADIATION RESEARCH
- Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy
- (2017) Victoria Dunne et al. RADIOTHERAPY AND ONCOLOGY
- Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers
- (2017) Claire Lhuillier et al. SEMINARS IN CANCER BIOLOGY
- A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid Malignancies
- (2017) Trisha M. Wise-Draper et al. Targeted Oncology
- Repair, Reuse, Recycle: The Expanding Role of Autophagy in Genome Maintenance
- (2017) Graeme Hewitt et al. TRENDS IN CELL BIOLOGY
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Apatinib alone or combined with radiotherapy in metastatic prostate cancer: Results from a pilot, multicenter study
- (2017) Feng Zhao et al. Oncotarget
- Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer
- (2017) Jung Hee Park et al. Oncotarget
- Targeting the PI3K/AKT/mTOR signaling pathway as an effectively radiosensitizing strategy for treating human oral squamous cell carcinoma in vitro and in vivo
- (2017) Chih-Chia Yu et al. Oncotarget
- Immune Modulation by Volatile Anesthetics
- (2016) Lindsay M. Stollings et al. ANESTHESIOLOGY
- Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high grade serous ovarian and breast cancer
- (2016) U.A. Matulonis et al. ANNALS OF ONCOLOGY
- Transforming growth factor β as regulator of cancer stemness and metastasis
- (2016) Claudia Bellomo et al. BRITISH JOURNAL OF CANCER
- Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer
- (2016) Brittany A. Simone et al. CELL CYCLE
- MET inhibition overcomes radiation resistance of glioblastoma stem‐like cells
- (2016) Francesca De Bacco et al. EMBO Molecular Medicine
- The VEGFR Inhibitor Cediranib Improves the Efficacy of Fractionated Radiotherapy in a Colorectal Cancer Xenograft Model
- (2016) Elodie Melsens et al. EUROPEAN SURGICAL RESEARCH
- Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
- (2016) Lu Cao et al. MEDICINE
- CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy
- (2016) H. E. Barker et al. MOLECULAR CANCER THERAPEUTICS
- Autophagy Regulates Chromatin Ubiquitination in DNA Damage Response through Elimination of SQSTM1/p62
- (2016) Yanan Wang et al. MOLECULAR CELL
- Treating cancer with selective CDK4/6 inhibitors
- (2016) Ben O'Leary et al. Nature Reviews Clinical Oncology
- A Phase Ib Study of BEZ235, a Dual Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) and Mammalian Target of Rapamycin (mTOR), in Patients With Advanced Renal Cell Carcinoma
- (2016) Maria I. Carlo et al. ONCOLOGIST
- Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells
- (2016) Tosol Yu et al. Oncotarget
- Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells
- (2015) S. U. Ahmed et al. CANCER RESEARCH
- TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity
- (2015) Claire Vanpouille-Box et al. CANCER RESEARCH
- The c-Met Tyrosine Kinase Inhibitor JNJ-38877605 Causes Renal Toxicity through Species-Specific Insoluble Metabolite Formation
- (2015) M. P. Lolkema et al. CLINICAL CANCER RESEARCH
- Taselisib (GDC-0032), a Potent -Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations
- (2015) Z. S. Zumsteg et al. CLINICAL CANCER RESEARCH
- Autophagy in malignant transformation and cancer progression
- (2015) L. Galluzzi et al. EMBO JOURNAL
- PI3K/mTOR pathway inhibition overcomes radioresistance via suppression of the HIF1-α/VEGF pathway in endometrial cancer
- (2015) Aki Miyasaka et al. GYNECOLOGIC ONCOLOGY
- Attenuation of the DNA Damage Response by Transforming Growth Factor-Beta Inhibitors Enhances Radiation Sensitivity of Non–Small-Cell Lung Cancer Cells In Vitro and In Vivo
- (2015) Shisuo Du et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Poly(ADP-ribosyl)ation-dependent Transient Chromatin Decondensation and Histone Displacement following Laser Microirradiation
- (2015) Hilmar Strickfaden et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study
- (2015) Kevin Harrington et al. JOURNAL OF CLINICAL ONCOLOGY
- Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
- (2015) Jordi Giralt et al. LANCET ONCOLOGY
- Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial
- (2015) Ricard Mesía et al. LANCET ONCOLOGY
- Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer
- (2015) YONGSHUN CHEN et al. Molecular Medicine Reports
- Loss of autophagy causes a synthetic lethal deficiency in DNA repair
- (2015) Emma Y. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AMPK-independent autophagy promotes radioresistance of human tumor cells under clinical relevant hypoxia in vitro
- (2015) Hassan Chaachouay et al. RADIOTHERAPY AND ONCOLOGY
- A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme
- (2014) Myrna R Rosenfeld et al. Autophagy
- Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumors
- (2014) Edward Sausville et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role of autophagy in high linear energy transfer radiation-induced cytotoxicity to tumor cells
- (2014) Xiaodong Jin et al. CANCER SCIENCE
- Combined Inhibition of Wee1 and PARP1/2 for Radiosensitization in Pancreatic Cancer
- (2014) D. Karnak et al. CLINICAL CANCER RESEARCH
- Abrogation of radioresistance in glioblastoma stem-like cells by inhibition of ATM kinase
- (2014) Ross Carruthers et al. Molecular Oncology
- ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1
- (2014) Peijing Zhang et al. NATURE CELL BIOLOGY
- An update on PARP inhibitors—moving to the adjuvant setting
- (2014) Amir Sonnenblick et al. Nature Reviews Clinical Oncology
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Beclin 1 and UVRAG Confer Protection from Radiation-Induced DNA Damage and Maintain Centrosome Stability in Colorectal Cancer Cells
- (2014) Jae Myung Park et al. PLoS One
- Radiosensitization of Pancreatic Cancer Cells In Vitro and In Vivo through Poly (ADP-ribose) Polymerase Inhibition with ABT-888
- (2014) Richard Tuli et al. Translational Oncology
- Vulnerabilities of PTEN-TP53-Deficient Prostate Cancers to Compound PARP-PI3K Inhibition
- (2014) E. Gonzalez-Billalabeitia et al. Cancer Discovery
- Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death
- (2014) Encouse B Golden et al. OncoImmunology
- NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro
- (2013) Wen-juan Wang et al. ACTA PHARMACOLOGICA SINICA
- Locoregional recurrence in patients with HER2 positive breast cancer
- (2013) Janaina Brollo et al. BREAST
- Cisplatin Resistance Associated with PARP Hyperactivation
- (2013) J. Michels et al. CANCER RESEARCH
- Caloric restriction augments radiation efficacy in breast cancer
- (2013) Anthony Saleh et al. CELL CYCLE
- Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
- (2013) A Ko et al. CELL DEATH AND DIFFERENTIATION
- ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
- (2013) L. Biddlestone-Thorpe et al. CLINICAL CANCER RESEARCH
- Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway
- (2013) Jie Ni et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019
- (2013) Donatella Vecchio et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor Activity
- (2013) Kevin M. Foote et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis
- (2013) Gangwen Han et al. NATURE MEDICINE
- Strategies for optimizing the response of cancer and normal tissues to radiation
- (2013) Everett J. Moding et al. NATURE REVIEWS DRUG DISCOVERY
- The ATM protein kinase: regulating the cellular response to genotoxic stress and more
- (2013) Yosef Shiloh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pharmacological Induction of Transforming Growth Factor-Beta1 in Rat Models Enhances Radiation Injury in the Intestine and the Heart
- (2013) Marjan Boerma et al. PLoS One
- Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation
- (2013) T. T. Batchelor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking
- (2013) T. Kondo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting radiation-resistant hypoxic tumour cells through ATR inhibition
- (2012) I M Pires et al. BRITISH JOURNAL OF CANCER
- Copy number alterations of c-MYC and PTEN are prognostic factors for relapse after prostate cancer radiotherapy
- (2012) Gaetano Zafarana et al. CANCER
- MYC Regulation of CHK1 and CHK2 Promotes Radioresistance in a Stem Cell-like Population of Nasopharyngeal Carcinoma Cells
- (2012) W.-J. Wang et al. CANCER RESEARCH
- Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β
- (2012) Matthew E. Hardee et al. CANCER RESEARCH
- Selective radiosensitization of p53 mutant pancreatic cancer cells by combined inhibition of Chk1 and PARP1
- (2012) Sean Vance et al. CELL CYCLE
- LY2109761 Attenuates Radiation-Induced Pulmonary Murine Fibrosis via Reversal of TGF- and BMP-Associated Proinflammatory and Proangiogenic Signals
- (2012) P. Flechsig et al. CLINICAL CANCER RESEARCH
- Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: Rationale for future randomised trials in human papilloma virus-negative disease
- (2012) Kevin Harrington et al. EUROPEAN JOURNAL OF CANCER
- AZD5438, an Inhibitor of Cdk1, 2, and 9, Enhances the Radiosensitivity of Non-Small Cell Lung Carcinoma Cells
- (2012) Pavithra Raghavan et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation
- (2012) E Fokas et al. Cell Death & Disease
- Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer
- (2012) Ashish Juvekar et al. Cancer Discovery
- Curative radiation therapy in prostate cancer
- (2011) Ulrika Harmenberg et al. ACTA ONCOLOGICA
- Blockade of TGF- Signaling by the TGF R-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
- (2011) M. Zhang et al. CANCER RESEARCH
- Sensitizing effect of 3-methyladenine on radiation-induced cytotoxicity in radio-resistant HepG2 cells in vitro and in tumor xenografts
- (2011) Hsien-Chun Tseng et al. CHEMICO-BIOLOGICAL INTERACTIONS
- TGF 1 Inhibition Increases the Radiosensitivity of Breast Cancer Cells In Vitro and Promotes Tumor Control by Radiation In Vivo
- (2011) F. Bouquet et al. CLINICAL CANCER RESEARCH
- Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity
- (2011) Wenzhuo Zhuang et al. INTERNATIONAL JOURNAL OF CANCER
- Induction of MET by Ionizing Radiation and Its Role in Radioresistance and Invasive Growth of Cancer
- (2011) Francesca De Bacco et al. JNCI-Journal of the National Cancer Institute
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Inhibition of Smad3 Expression in Radiation-Induced Fibrosis Using a Novel Method for Topical Transcutaneous Gene Therapy
- (2010) Judy W. Lee et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
- (2010) A. Choudhury et al. CANCER RESEARCH
- Mechanism of Radiosensitization by the Chk1/2 Inhibitor AZD7762 Involves Abrogation of the G2Checkpoint and Inhibition of Homologous Recombinational DNA Repair
- (2010) Meredith A. Morgan et al. CANCER RESEARCH
- Autocrine regulation of glioblastoma cell-cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay
- (2010) Petra Knizetova et al. CELL CYCLE
- In vitro and In vivo Radiation Sensitization of Human Tumor Cells by a Novel Checkpoint Kinase Inhibitor, AZD7762
- (2010) J. B. Mitchell et al. CLINICAL CANCER RESEARCH
- Current Advancement in Radiation Therapy for Uterine Cervical Cancer
- (2010) Takashi NAKANO et al. JOURNAL OF RADIATION RESEARCH
- Low Doses of Ionizing Radiation Promote Tumor Growth and Metastasis by Enhancing Angiogenesis
- (2010) Inês Sofia Vala et al. PLoS One
- Endothelial Membrane Remodeling Is Obligate for Anti-Angiogenic Radiosensitization during Tumor Radiosurgery
- (2010) Jean-Philip Truman et al. PLoS One
- Safety, tolerability, pharmacokinetics and pharmacodynamics of the oral cyclin-dependent kinase inhibitor AZD5438 when administered at intermittent and continuous dosing schedules in patients with advanced solid tumours
- (2009) D. S. Boss et al. ANNALS OF ONCOLOGY
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion
- (2009) S. E. Golding et al. MOLECULAR CANCER THERAPEUTICS
- Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status
- (2008) Y Akashi et al. BRITISH JOURNAL OF CANCER
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
- (2008) Jan B. Vermorken et al. NEW ENGLAND JOURNAL OF MEDICINE
- NF-κB-MediatedHER2Overexpression inRadiation-Adaptive Resistance
- (2008) Ning Cao et al. RADIATION RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now